| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000019156 |
| Receipt No. | R000022113 |
| Scientific Title | Kanagawa-Acute cardiovascular registry |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2021/10/03 (Ver. 8) |
| Basic information | ||
| Public title | Kanagawa-Acute cardiovascular registry | |
| Acronym | K-ACTIVE | |
| Scientific Title | Kanagawa-Acute cardiovascular registry | |
| Scientific Title:Acronym | K-ACTIVE | |
| Region |
|
|
| Condition | ||
| Condition | Acute myocardial infarction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the incidence of cardiovascular event (in hospital, 12months) in patients with acute myocardial infarction in Kanagawa |
| Basic objectives2 | Others |
| Basic objectives -Others | To compare the data of acute myocardial infarction to other prefectures |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of cardiovascular event (in hospital, 12months) |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | acute myocardial infarction (ST-elevation and non ST-elevation) within 24 hours from onset (including cardiopulmonary arrest) | |||
| Key exclusion criteria | none | |||
| Target sample size | 2000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Showa University Fujigaoka Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | 227-8501 | ||||||
| Address | 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Kanagawa, Jaoan | ||||||
| TEL | 0459711151 | ||||||
| hrsuzuki@med.showa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Showa University Fujigaoka Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | 227-8501 | ||||||
| Address | 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Kanagawa, Jaoan | ||||||
| TEL | 045-971-1151 | ||||||
| Homepage URL | |||||||
| hrsuzuki@med.showa-u.ac.jp | |||||||
| Sponsor | |
| Institute | Conference in Kanagawa cardiovascular emergency and registry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Showa University Fujigaoka Hospital |
| Address | 1-30 Fujigaoka, Aoba-ku, Yokohamashi, Kanagawa |
| Tel | 0459711151 |
| hrsuzuki@med.showa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 昭和大学藤が丘病院他55施設 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | |||||||
| Results | 10,140 cases were registered at 10/02/2021. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | (1) Study design: registry
(2) Study period: 2015.10.1-(Indefinite) (3) Patients: Acute myocardial infarction (ST-elevation and non ST-elevation) addmitted within 24 hours from onset (including cardiopulmonary arrest) to registered hospital in Kanagawa (4)Registration item 1.General information: admission day, time 2. Patient information: age, gender, hospital visit, onset time, onset-door-time 3. Complication: DM, DLp, HT, smoking, history of hospital visit 4. Visit information: BP, Pulse, Rhythm, Killip, CPA, Cr 5. Prehospital ECG: recording, transmission 6. AMI: type, site, history, peak CK, peak CKMB 7. Therapy: PCI, thrombolysis 8. Prognosis: in-hospital, 30 days, 12 months, reason of death, MACE |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022113 |